Jason Adair, serving as the Chief Business Officer for Liquidia Corp (NASDAQ:LQDA), executed a transaction involving the sale of 7,863 shares of common stock on July 13, 2026. The aggregate value realized from this divestment stood at $562,288. The execution price for these shares ranged between $71.39 and $71.52. The transaction was conducted under the parameters of a Rule 10b5-1 trading plan, a mechanism designed to facilitate pre-arranged sales, which Mr. Adair initially adopted on December 15, 2023. The primary motivation cited for this specific sale was to cover tax obligations associated with the settlement of restricted stock units (RSUs) and performance stock units (PSUs).
The sale occurred against a backdrop of significant price appreciation for Liquidia. The stock had recently climbed to $76.47, marking a substantial 427% return over the preceding twelve-month period. Market analysis from InvestingPro suggests that despite this surge, Liquidia may currently be trading below its estimated fair value, presenting a potential valuation discrepancy according to their models.
Prior to the divestment, Mr. Adair had acquired a substantial block of 10,251 shares on July 10, 2026. This acquisition was not a market purchase but rather the result of equity settlement. The shares were obtained at a price of $0.0 per share, converting on a one-for-one basis from RSUs and PSUs. The breakdown of this acquisition includes 3,907 shares from RSUs granted on January 11, 2023, 2,475 shares from PSUs granted on January 11, 2024, and 3,869 shares from PSUs granted on January 11, 2025.
Following these recent transactions, Mr. Adair's direct holdings in Liquidia Corp common stock total 217,126 shares. This balance sheet position includes a variety of unvested equity awards that have not yet converted to common stock. Specifically, he holds 7,812 unvested RSUs from a July 6, 2023 grant, 14,845 unvested RSUs from a January 11, 2024 grant, and 38,684 unvested PSUs from a January 11, 2025 grant. Additionally, he retains 27,683 unvested RSUs from a January 16, 2026 grant and 12,023 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
Corporate developments for Liquidia extend beyond executive transactions. The company announced its inclusion in the S&P SmallCap 600 Index, effective June 22. This index tracks 600 U.S. small-cap companies based on market capitalization and other specific criteria, signaling a shift in the company's market classification.
Analyst sentiment regarding Liquidia shows divergence. BofA Securities downgraded the stock rating from Buy to Neutral, citing a balanced risk-reward profile following recent gains, though they raised the price target to $79. H.C. Wainwright adjusted its price target to $75 while maintaining a Buy rating, influenced by a Supreme Court ruling that may benefit Liquidia's ongoing legal case. Raymond James reiterated a Strong Buy rating with a $68 price target, also highlighting positive implications from the same Supreme Court decision involving Hikma Pharmaceuticals and Amarin.